ETOPOSIDE AND HIGH-DOSE CISPLATIN IN GOOD-RISK PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF THE LUNG

被引：0

作者：

ARDIZZONI, A

CANOBBIO, L

PRONZATO, P

RUBAGOTTI, A

DEPALMA, M

BARACCO, F

SERRANO, J

SERRANO, S

FARAVELLI, B

NOSENZO, M

FELLETTI, R

ROSSO, R

机构：

[1] IST NAZL RIC CANC,SERV EPIDEMIOL CLIN & SPERIMENTAZ CONTROLLATE,I-16132 GENOVA,ITALY

[2] USL 13,DIV BRONCOL,GENOVA,ITALY

[3] USL 13,DIV CHIRURG TORAC,GENOVA,ITALY

[4] USL 11,DIV PNEUMOL,GENOVA,ITALY

[5] USL 13,DIV PNEUMOL 1,GENOVA,ITALY

来源：

CANCER TREATMENT REPORTS | 1986年 / 70卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：891 / 892

页数：2

共 13 条

[1] AISNER J, 1981, CANCER TREAT REP, V65, P979
[2] DHINGRA HM, 1984, CANCER TREAT REP, V68, P671
[3] EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO
[4] 2-4
[5] CISPLATIN AND VINDESINE COMBINATION CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE LUNG - A RANDOMIZED TRIAL INVESTIGATING 2 DOSAGE SCHEDULES
GRALLA, RJ
CASPER, ES
KELSEN, DP
BRAUN, DW
DUKEMAN, ME
MARTINI, N
YOUNG, CW
GOLBEY, RB
[J]. ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) : 414 - 420
[6] LONGEVAL E, 1982, CANCER, V50, P2751, DOI 10.1002/1097-0142(19821215)50:12<2751::AID-CNCR2820501210>3.0.CO
[7] 2-3
[8] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[9] 2-6
[10] CIS-PLATINUM (DDP) AND VP16-213 (ETOPOSIDE) COMBINATION CHEMOTHERAPY FOR ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II CLINICAL-TRIAL
MITROU, PS
GRAUBNER, M
BERDEL, WE
MENDE, S
GROPP, C
DIEHL, V
KLIPPSTEIN, TH
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (03): : 347 - 351